Literature DB >> 24421386

C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophages.

Javier Rodriguez-Ubreva1, Laura Ciudad, Chris van Oevelen, Maribel Parra, Thomas Graf, Esteban Ballestar.   

Abstract

MicroRNAs (miRNAs) exert negative effects on gene expression and influence cell lineage choice during hematopoiesis. C/EBPa-induced pre-B cell-to-macrophage transdifferentiation provides an excellent model to investigate the contribution of miRNAs to hematopoietic cell identity, especially because the two cell types involved fall into separate lymphoid and myeloid branches. In this process, efficient repression of the B cell-specific program is essential to ensure transdifferentation and macrophage function. miRNA profiling revealed that upregulation of miRNAs is highly predominant compared with downregulation and that C/EBPa directly regulates several upregulated miRNAs. We also determined that miRNA 34a (miR-34a) and miR-223 sharply accelerate C/EBPa-mediated transdifferentiation, whereas their depletion delays this process. These two miRNAs affect the transdifferentiation efficiency and activity of macrophages, including their lipopolysaccharide (LPS)-dependent inflammatory response. miR-34a and miR-223 directly target and downregulate the lymphoid transcription factor Lef1, whose ectopic expression delays transdifferentiation to an extent similar to that seen with miR-34a and miR-223 depletion. In addition, ectopic introduction of Lef1 in macrophages causes upregulation of B cell markers, including CD19, Pax5, and Ikzf3. Our report demonstrates the importance of these miRNAs in ensuring the erasure of key B cell transcription factors, such as Lef1, and reinforces the notion of their essential role in fine-tuning the control required for establishing cell identity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24421386      PMCID: PMC3958044          DOI: 10.1128/MCB.01487-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

Review 1.  Transcription factor regulation of B lineage commitment.

Authors:  B L Kee; C Murre
Journal:  Curr Opin Immunol       Date:  2001-04       Impact factor: 7.486

Review 2.  microRNAs: tiny regulators with great potential.

Authors:  V Ambros
Journal:  Cell       Date:  2001-12-28       Impact factor: 41.582

3.  Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism.

Authors:  T Reya; M O'Riordan; R Okamura; E Devaney; K Willert; R Nusse; R Grosschedl
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

4.  Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor.

Authors:  Richard Dahl; Jonathan C Walsh; David Lancki; Peter Laslo; Sangeeta R Iyer; Harinder Singh; M Celeste Simon
Journal:  Nat Immunol       Date:  2003-09-07       Impact factor: 25.606

5.  Stepwise reprogramming of B cells into macrophages.

Authors:  Huafeng Xie; Min Ye; Ru Feng; Thomas Graf
Journal:  Cell       Date:  2004-05-28       Impact factor: 41.582

6.  Functional macrophage cell lines transformed by Abelson leukemia virus.

Authors:  W C Raschke; S Baird; P Ralph; I Nakoinz
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

7.  The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.

Authors:  Su Jung Song; Keisuke Ito; Ugo Ala; Lev Kats; Kaitlyn Webster; Su Ming Sun; Mojca Jongen-Lavrencic; Katia Manova-Todorova; Julie Teruya-Feldstein; David E Avigan; Ruud Delwel; Pier Paolo Pandolfi
Journal:  Cell Stem Cell       Date:  2013-07-03       Impact factor: 24.633

8.  C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo.

Authors:  Victoria Heath; Hyung Chan Suh; Matthew Holman; Katie Renn; John M Gooya; Sarah Parkin; Kimberly D Klarmann; Mariaestela Ortiz; Peter Johnson; Jonathan Keller
Journal:  Blood       Date:  2004-04-08       Impact factor: 22.113

9.  The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy.

Authors:  Shuyang Yu; Xinyuan Zhou; Farrah C Steinke; Chengyu Liu; Shann-Ching Chen; Oksana Zagorodna; Xuefang Jing; Yoshifumi Yokota; David K Meyerholz; Charles G Mullighan; C Michael Knudson; Dong-Mei Zhao; Hai-Hui Xue
Journal:  Immunity       Date:  2012-10-25       Impact factor: 31.745

10.  Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation.

Authors:  Vit Pospisil; Karin Vargova; Juraj Kokavec; Jana Rybarova; Filipp Savvulidi; Anna Jonasova; Emanuel Necas; Jiri Zavadil; Peter Laslo; Tomas Stopka
Journal:  EMBO J       Date:  2011-09-06       Impact factor: 11.598

View more
  17 in total

1.  LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.

Authors:  Jiaqian Liang; Yirong Li; Garrett Daniels; Karen Sfanos; Angelo De Marzo; Jianjun Wei; Xin Li; Wenqiang Chen; Jinhua Wang; Xuelin Zhong; Jonathan Melamed; Jun Zhao; Peng Lee
Journal:  Mol Cancer Res       Date:  2015-01-13       Impact factor: 5.852

Review 2.  Osteoclastic microRNAs and their translational potential in skeletal diseases.

Authors:  Kazuki Inoue; Shinichi Nakano; Baohong Zhao
Journal:  Semin Immunopathol       Date:  2019-10-07       Impact factor: 9.623

Review 3.  Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.

Authors:  Larion Santiago; Garrett Daniels; Dongwen Wang; Fang-Ming Deng; Peng Lee
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

4.  Repression of SIRT1 promotes the differentiation of mouse induced pluripotent stem cells into neural stem cells.

Authors:  Bin Hu; Ye Guo; Chunyuan Chen; Qing Li; Xin Niu; Shangchun Guo; Aijun Zhang; Yang Wang; Zhifeng Deng
Journal:  Cell Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.046

5.  Dynamics of alternative splicing during somatic cell reprogramming reveals functions for RNA-binding proteins CPSF3, hnRNP UL1, and TIA1.

Authors:  Claudia Vivori; Panagiotis Papasaikas; Ralph Stadhouders; Bruno Di Stefano; Anna Ribó Rubio; Clara Berenguer Balaguer; Serena Generoso; Anna Mallol; José Luis Sardina; Bernhard Payer; Thomas Graf; Juan Valcárcel
Journal:  Genome Biol       Date:  2021-06-03       Impact factor: 17.906

Review 6.  MicroRNAs in B-cells: from normal differentiation to treatment of malignancies.

Authors:  Sara Correia Marques; Maria Bach Laursen; Julie Støve Bødker; Malene Krag Kjeldsen; Steffen Falgreen; Alexander Schmitz; Martin Bøgsted; Hans Erik Johnsen; Karen Dybkaer
Journal:  Oncotarget       Date:  2015-01-01

7.  miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.

Authors:  John Fischer; Stefano Rossetti; Arani Datta; Kevin Eng; Alessandro Beghini; Nicoletta Sacchi
Journal:  Mol Cancer       Date:  2015-01-23       Impact factor: 27.401

8.  NF-κB-direct activation of microRNAs with repressive effects on monocyte-specific genes is critical for osteoclast differentiation.

Authors:  Lorenzo de la Rica; Antonio García-Gómez; Natalia R Comet; Javier Rodríguez-Ubreva; Laura Ciudad; Roser Vento-Tormo; Carlos Company; Damiana Álvarez-Errico; Mireia García; Carmen Gómez-Vaquero; Esteban Ballestar
Journal:  Genome Biol       Date:  2015-01-05       Impact factor: 13.583

9.  Familial adenomatous patients with desmoid tumours show increased expression of miR-34a in serum and high levels in tumours.

Authors:  Sarah-Jane Walton; Amy Lewis; Rosemary Jeffery; Hannah Thompson; Roger Feakins; Eleni Giannoulatou; Christopher Yau; James O Lindsay; Susan K Clark; Andrew Silver
Journal:  Oncoscience       Date:  2016-06-30

10.  Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis.

Authors:  Elisa Bianchi; Samantha Ruberti; Sebastiano Rontauroli; Paola Guglielmelli; Simona Salati; Chiara Rossi; Roberta Zini; Enrico Tagliafico; Alessandro Maria Vannucchi; Rossella Manfredini
Journal:  Int J Mol Sci       Date:  2017-01-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.